Bio Green Med Solution, Inc.
BGMSNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $747,000 | $43,000 | $420,000 | $0 | $0 | $0 |
| Operating income | −$8.4M | −$12.0M | −$25.5M | −$27.7M | −$22.9M | −$10.6M |
| Net income | −$3.0M | −$11.2M | −$22.6M | −$21.2M | −$18.9M | −$8.4M |
| Total assets | $8.2M | $4.1M | $8.8M | $28.1M | $42.6M | $36.8M |
| Total liabilities | $1.3M | $6.3M | $8.2M | $7.6M | $5.3M | $3.5M |
| Equity | $6.8M | −$2.2M | $607,000 | $15.9M | $37.7M | $33.3M |
| EPS (diluted) | $-6.45 | $-2.09 | $-26.75 | $-27.24 | $-2.14 | $-3.42 |
| Shares out. | 207.3M | 1.3M | 12.5M | 10.0M | 7.1M | 17.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −1128.1%
- Net margin
- −401.3%
- Return on equity
- −43.8%
- Return on assets
- −36.6%
- Return on capital (ROCE)
- −123.0%
- Liabilities / assets
- 16.4%
- Debt / equity
- 0.20×
- Book value / share
- $0.03
- Revenue growth (YoY)
- 1637.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -178.61distress
- Accruals / assets
- 21.6%high accruals
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
- NT 10-Qmissed a reporting deadline ↗May 18, 2010
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Yap Kim ChoyPassive (13G)May 12, 2026
- Ong Yee LungPassive (13G)Mar 13, 2026
- Kua Khai LoonPassive (13G)Mar 13, 2026
- Doris Wong Sing EeActivist (13D)Nov 13, 2025
- Fitters Diversified BerhadPassive (13G)Oct 23, 2025
- Armistice Capital, LlcPassive (13G)Aug 14, 2025
- Lazar David E.Activist (13D)Aug 8, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Kiu Cu SengOfficer — Chief Financial Officer | Nov 12, 2025 | Grant | 200,000 | $1.40 |
| Doris Wong Sing EeOfficer — Chief Executive Officer | Nov 12, 2025 | Grant | 300,178 | $1.40 |
| Yap Kim Choy10% owner | Nov 5, 2025 | Sell | 28,540 | $1.70 |
| Kua Khai Loon10% owner | Nov 5, 2025 | J | 467,535 | $0.00 |
| Ong Yee Lung10% owner | Nov 5, 2025 | J | 467,535 | $0.00 |
| Yap Kim Choy10% owner | Oct 30, 2025 | Sell | 112,260 | $1.81 |
| Kua Khai Loon10% owner | Oct 30, 2025 | Sell | 242,477 | $1.80 |
| Ong Yee Lung10% owner | Oct 30, 2025 | Sell | 248,814 | $1.80 |
| Yap Kim Choy10% owner | Oct 29, 2025 | Sell | 110,749 | $1.83 |
| Yap Kim Choy10% owner | Oct 28, 2025 | Sell | 13,111 | $1.83 |
| Yap Kim Choy10% owner | Oct 27, 2025 | Sell | 120,250 | $2.12 |
| Ong Yee Lung10% owner | Oct 24, 2025 | Sell | 19,858 | $1.99 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 26,327 | 1.0 | -28.1% |
| Apr 30, 2026 | 36,638 | 1.0 | -38.3% |
| Apr 15, 2026 | 59,393 | 1.0 | +155.1% |
| Mar 31, 2026 | 23,283 | 1.0 | +10.7% |
| Mar 13, 2026 | 21,039 | 1.0 | -7.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosureMay 14, 2026
- Other material eventApr 13, 2026
- Results of operations · Regulation FD disclosureMar 30, 2026
- Delisting / listing-standard noticeMar 13, 2026
- Other material eventJan 12, 2026
- Results of operations · Regulation FD disclosureNov 13, 2025
- Entered a material agreement · Unregistered equity saleNov 6, 2025
- Other material eventOct 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QMay 15, 2026
- 8-KMay 14, 2026
- SCHEDULE 13G/AMay 12, 2026
- DEFR14AMay 1, 2026
- DEF 14AApr 27, 2026
- 8-KApr 13, 2026
- 10-KMar 30, 2026
- 8-KMar 30, 2026
- SCHEDULE 13G/AMar 13, 2026
- SCHEDULE 13G/AMar 13, 2026
- 8-KMar 13, 2026
- 8-KJan 12, 2026
- S-8Nov 28, 2025
- 10-K/ANov 26, 2025
- 4Nov 13, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.